SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-015302
Filing Date
2022-03-28
Accepted
2022-03-28 08:30:51
Documents
13
Period of Report
2022-03-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea157434-8k_180life.htm   iXBRL 8-K 33235
  Complete submission text file 0001213900-22-015302.txt   255493

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20220328.xsd EX-101.SCH 3798
3 XBRL DEFINITION FILE atnf-20220328_def.xml EX-101.DEF 26891
4 XBRL LABEL FILE atnf-20220328_lab.xml EX-101.LAB 36930
5 XBRL PRESENTATION FILE atnf-20220328_pre.xml EX-101.PRE 25513
7 EXTRACTED XBRL INSTANCE DOCUMENT ea157434-8k_180life_htm.xml XML 5706
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 22773286
SIC: 2834 Pharmaceutical Preparations